Drugs that contain Naloxone Hydrochloride; Oxycodone Hydrochloride
1. Drug name - TARGINIQ
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9073933 | PURDUE PHARMA LP | Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| US9522919 | PURDUE PHARMA LP | Oxycodone compositions |
Mar, 2025
(2 years from now) | |
| CN101812065B | PURDUE PHARMA LP | Contains Less Than 25 Ppm Ppm Of 14-Hydroxymethyl Codeine To Oxycodone Hydrochloride Ketone Can Be Ketone |
Mar, 2025
(2 years from now) | |
| CN1960994A | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| CN102838607B | PURDUE PHARMA LP | Preparation Contains Less Than 25 Ppm Of 14-Hydroxide Can Be Oxycodone Method By Hydrochloric Acid |
Mar, 2025
(2 years from now) | |
| CN1960994B | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| CN101812065A | PURDUE PHARMA LP | A Method For Preparing Oxycodone Hydrochloride Composition With Less Than 25Ppm Of 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| CN102127086A | PURDUE PHARMA LP | Method For Preparing Pancodine Composition Containing Less Than 25 Ppm Of 14-Oxycodone |
Mar, 2025
(2 years from now) | |
| CN102887903A | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| CN102127086B | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| CN102838607A | PURDUE PHARMA LP | Method For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm Of 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| CN102887903B | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2426132B1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Compositions Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2305683A1 | PURDUE PHARMA LP | Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2305683B8 | PURDUE PHARMA LP | Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP1730151B1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2316837B1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP1730151A4 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP1730151B2 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2316837A1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2319846A1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2319846B1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2305683B1 | PURDUE PHARMA LP | Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP1730151A1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| EP2426132A1 | PURDUE PHARMA LP | Process For Preparing Oxycodone Hydrochloride Compositions Having Less Than 25Ppm 14-Hydroxycodeinone |
Mar, 2025
(2 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8846090 | PURDUE PHARMA LP | Matrix for sustained, invariant and independent release of active compounds |
Apr, 2023
(6 months from now) | |
| US8846091 | PURDUE PHARMA LP | Matrix for sustained, invariant and independent release of active compounds |
Apr, 2023
(6 months from now) | |
| US9555000 | PURDUE PHARMA LP | Pharmaceutical preparation containing oxycodone and naloxone |
Apr, 2023
(6 months from now) | |
| US9907793 | PURDUE PHARMA LP | Pharmaceutical preparation containing oxycodone and naloxone |
Apr, 2023
(6 months from now) | |
Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 5MG;10MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 10MG;20MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
| 20MG;40MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.